Memo to Lab Compliance Managers: Set Your Goals for 2023
Learn why this is the perfect time of the year to mobilize your board members.
Author Information
Glenn S. Demby
Glenn S. Demby is an award-winning journalist with a track record of telling business professionals who aren’t lawyers how to comply with the parts of the law that affect their day-to-day operations. He has expertise in numerous aspects of law including employment, labor, health care, tax, payroll, benefits, and education. He won the Specialized Information Publishing Association’s editorial excellence award four years in a row. A graduate of Columbia University School of Law, he practiced as a corporate lawyer on Wall Street prior to his career as a business-to-business journalist. In addition to overseeing the content of the four G2 Intelligence monthly briefings, he contributes to the daily Laboratory and Pathology Insider.
Posts by the Author
Q3 Lab Company Earnings Take a Hit
A decline in COVID-19 testing demand, along with a challenging economy, made for a difficult quarter for diagnostics companies.
Amazon Makes Third Attempt to Disrupt Healthcare Business
Having twice failed to disrupt health care, Amazon opts for a different strategy this time around—and it may just work.
December 2022 FDA Watch: More Approvals in US than EU
A high volume of FDA approvals for new tests and diagnostic products made up for the relatively low number of approvals in the EU.
How to Use Mobile Apps to Optimize T&E System Performance in Labs
Automating travel and expense significantly improves performance, but adding mobility takes such improvements to a much higher level.
A Brief Look at the COVID-19 Saliva Testing Global Market
The recent FDA approval of an OTC test shows that COVID-19 saliva testing may be poised for bigger and better things in the years ahead.
Strategic Deals in DX Space Remain Low in Number, but High in Impact
Though only seven transactions were announced or closed in November, two were billion-dollar deals.
Amazon Launches New Venture to Disrupt Healthcare
The company’s third attempt at shaking up the healthcare industry, Amazon Clinic, might just prove the charm.
Current Diagnostics Merger & Acquisition Trends
M&A deals in the diagnostics industry have been lower in number, but higher in impact in recent months.
December 2022 Labs in Court: FCA and a Sex Discrimination Case Dismissed
Key cases over the past month were the usual FCA-related fare, apart from a dismissed sex discrimination case.
